❌

Normal view

There are new articles available, click to refresh the page.
Today β€” 17 June 2024Main stream

How A.I. Is Revolutionizing Drug Development

In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway.

Chips in a container at Terray Therapeutics in Monrovia, Calif. Each of the custom-made chips has millions of minuscule wells for measuring drug screening reactions quickly and accurately.
Before yesterdayMain stream

FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.

Β© Noel Celis/Agence France-Presse β€” Getty Images

A seizure of the drug MDMA, known as Ecstasy or molly. It and other psychoactive drugs are still classified as illegal drugs with a potential for abuse.

Setback Deals Blow to Neuralink’s First Brain Implant Patient, but He Stays Upbeat

22 May 2024 at 11:57
Elon Musk’s first human experiment with a computerized brain device developed significant flaws, but the subject, who is paralyzed, has few regrets.

Β© Rebecca Noble for The New York Times

FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer

16 May 2024 at 16:59
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.

Β© Joe Buglewicz for The New York Times

Martha Warren, 65, of Westerly, R.I., found out last year that she had small cell lung cancer, and joined the tarlatamab clinical trial. She said she now feels as good as before her diagnosis.
❌
❌